Gufic Biosciences Ltd (BOM:509079)
₹ 487 13.45 (2.84%) Market Cap: 48.84 Bil Enterprise Value: 52.15 Bil PE Ratio: 56.04 PB Ratio: 9.17 GF Score: 94/100

Q4 2021 Gufic Biosciences Ltd Earnings Call Transcript

Jun 04, 2021 / NTS GMT
Release Date Price: ₹190.65 (+0.77%)
Operator

Ladies and gentlemen, good day, and welcome to Gufic Biosciences Limited Investor Meet. (Operator Instructions). Please note now this conference is being recorded. I now hand the conference over to Mr. Pranav Choksi, CEO from Gufic Biosciences Limited. Thank you, and over to you, sir.

Pranav Choski
Gufic Biosciences Limited. - CEO

Yes, thanks Steve. Good afternoon, hello, I would say investors and who have been interested in Gufic, all this long. Firstly, I'd just like to confirm with Steven once again. Steve and I hope my audio quality is fine so I'll proceed to the presentation.

Operator

Yes sir, we can hear you clearly, you may proceed.

Pranav Choski
Gufic Biosciences Limited. - CEO

Alright, thank you. I'm Pranav Choksi. I am the CEO of Gufic Biosciences Limited, and I'm basically a B.Pharm. I did my undergrad from [Mumbai] University and then I did my MSc in Biotechnology from Johns Hopkins, United States. And I have been with Gufic, as professionally involved since last 13 to 14

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot